Cargando…

早期非小细胞肺癌的微创介入治疗

Lung cancer is the most common cancer and the leading cause of cancer death in the world, among which non-small cell lung cancer (NSCLC) accounts for about 85% of the total lung cancer. With the widespread of computed tomography (CT) and other imaging screening methods, the pathological types of lun...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309551/
https://www.ncbi.nlm.nih.gov/pubmed/32106639
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.01
_version_ 1783549231850586112
collection PubMed
description Lung cancer is the most common cancer and the leading cause of cancer death in the world, among which non-small cell lung cancer (NSCLC) accounts for about 85% of the total lung cancer. With the widespread of computed tomography (CT) and other imaging screening methods, the pathological types of lung cancer have changed from central squamous cell carcinoma to the early-stage lung adenocarcinoma, which is manifested as isolated pulmonary nodules and ground glass nodules on CT. Early diagnosis and treatment of lung cancer is of crucial clinical significance, and the continuous development and improvement of minimally invasive interventional techniques provide more options for lung cancer treatment, such as stereotactic radiation, percutaneous ablation, and bronchial intervention. This paper will make a review on the principle, advantages, disadvantages and prospects of minimally invasive interventional therapy commonly used in clinical practice.
format Online
Article
Text
id pubmed-7309551
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-73095512020-06-24 早期非小细胞肺癌的微创介入治疗 Zhongguo Fei Ai Za Zhi 肺癌介入专题 Lung cancer is the most common cancer and the leading cause of cancer death in the world, among which non-small cell lung cancer (NSCLC) accounts for about 85% of the total lung cancer. With the widespread of computed tomography (CT) and other imaging screening methods, the pathological types of lung cancer have changed from central squamous cell carcinoma to the early-stage lung adenocarcinoma, which is manifested as isolated pulmonary nodules and ground glass nodules on CT. Early diagnosis and treatment of lung cancer is of crucial clinical significance, and the continuous development and improvement of minimally invasive interventional techniques provide more options for lung cancer treatment, such as stereotactic radiation, percutaneous ablation, and bronchial intervention. This paper will make a review on the principle, advantages, disadvantages and prospects of minimally invasive interventional therapy commonly used in clinical practice. 中国肺癌杂志编辑部 2020-06-20 /pmc/articles/PMC7309551/ /pubmed/32106639 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.01 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 肺癌介入专题
早期非小细胞肺癌的微创介入治疗
title 早期非小细胞肺癌的微创介入治疗
title_full 早期非小细胞肺癌的微创介入治疗
title_fullStr 早期非小细胞肺癌的微创介入治疗
title_full_unstemmed 早期非小细胞肺癌的微创介入治疗
title_short 早期非小细胞肺癌的微创介入治疗
title_sort 早期非小细胞肺癌的微创介入治疗
topic 肺癌介入专题
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309551/
https://www.ncbi.nlm.nih.gov/pubmed/32106639
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.01
work_keys_str_mv AT zǎoqīfēixiǎoxìbāofèiáidewēichuàngjièrùzhìliáo
AT zǎoqīfēixiǎoxìbāofèiáidewēichuàngjièrùzhìliáo
AT zǎoqīfēixiǎoxìbāofèiáidewēichuàngjièrùzhìliáo
AT zǎoqīfēixiǎoxìbāofèiáidewēichuàngjièrùzhìliáo
AT zǎoqīfēixiǎoxìbāofèiáidewēichuàngjièrùzhìliáo